Is there life beyond Keytruda? Merck makes its case by Arlene Weintraub Thursday, June 20, 2019 Merck CEO Ken Frazier and his colleagues vowed during the company's Investor Day that a healthy pipeline will drive margin expansion.
Merck cancer, vaccine execs land promotions in commercial rejig by Carly Helfand Tuesday, December 11, 2018 Merck & Co. boasted some major sales success this year, but the company’s commercial organization will still get a makeover for 2019.
